Introduction
Wegener's granulomatosis is an uncommon immunopathological disease characterized by necrotizing granulomatosis in the upper and lower respiratory tracts combined with glomerulonephritis. The annual incidence of Wegener's granulomatosis is 8.5/million. 1 This small vessel vasculitis is comprised of a heterogeneous group of uncommon disorders that are prone to cycles of remission and relapse. This rare disease has an estimated prevalence of 3 per 100,000 persons affected. While much more common in whites when compared to blacks, the disease shows no gender affinity with 1:1 male to female ratio. Despite advances in the diagnosis and treatment of the ANCA-associated vasculitis (AAV), 20-40% of patients with pauci-immune renal vasculitis develop endstage renal disease (ESRD) and has to be treated with renal replacement therapy. 2 Renal transplantation has been recognized as an option for renal replacement therapy in patients with Wegener's granulamotosis (WG). 3 i n d i a n j o u r n a l o f t r a n s p l a n t a t i o n 9 ( 2 0 1 5 ) 1 5 9 -1 6 1 a r t i c l e i n f o 2.
Case report
A 41-year-old male of resident of Lucknow, Uttar Pradesh, India was planned for live donor renal transplant. Patient was diagnosed as having bilateral small kidneys in august 2010 and was medically managed for chronic kidney disease (CKD) since then using multiple oral anti-hypertensive are Clonidine 0.1 mg, Nicardia R 20 mg thrice daily and Minipress-xl 7.5 mg once daily. Patient was relatively asymptomatic till February 2013, when he started having cough with blood stained sputum along with respiratory distress. He was hospitalized and was given renal replacement therapy assuming fluid overload. For respiratory distress, the patient was given noninvasive ventilator support using, BiPAP support in ICU. During his stay in ICU, his antineutrophil cytoplasmic autoantibody (ANCA) screening came to be positive -4+P, MPO -295.0 AU/ml, PR3 -<3.0 AU/ml, Anti-MPO (ANCA) by ELISA came to be positive with values of 54.6 AU/ml, while Anti-GBM < 3.0 AU/ml and diagnosed as having WG. Patient was then started on prednisolone 30 mg and cyclophosphamide 75 mg once daily. Patient's condition gradually improved and was discharged from hospital after 12 days with renal transplant prospect in future. Now, the patient was planned for the renal transplantation, so further workup was done as per our institute protocol. On physical examination, the blood pressure was 160/106 mmHg, and pulse rate was 84/min with oxygen saturation of 95% on air. His chest X-ray revealed bilateral interstitial infiltrates with right more than left. The PFT revealed an obstructive airway pattern. 2D-echocardiography showed concentric LVH with normal LV size and contractility and grade-1, diastolic dysfunction. His blood investigation revealed Hb of 13.8 gm%, TLC 11,300, platelet 196,000, PT 12/13 s, INR 0.9, aPTT 27.7/ 27.7 s, BUN 98, serum creatinine 8.7.
In view of latest episode of chest complication managed in ICU, COPD and possibility of airway involvement because of WG, we planned the renal transplant to be done under combined spinal and epidural anesthesia (CSEA). After counseling and consent, patient was taken into operation theater, and all routine monitors were set on and intravenous line was secured. Injection hydrocortisone 100 mg was given to avoid Addisonian crises, as the patient was considered as steroid dependent because of WG, as per the immunological consultation. Taking care of the fistula in left hand, an arterial line (22G) was secured using local anesthesia under ultrasound guidance in the right hand. The right internal jugular was cannulated under ultrasound guidance (SonoSite, USA) for CVP measurement after local infiltration under strict aseptic precaution. An CSEA placement was done in lateral decubitus with 18G epidural tuohy needle and 27G spinal needle by needle-through-needlesingle space technique (Portex, Minipack, Smiths, UK) under strict asepsis at L2-L3 level after 2% xylocard infiltration. With the use of LOR technique, epidural space was confirmed, epidural catheter was placed and 3 ml of 2% xylocaine adrenaline was given as test dose. In the same space, spinal anesthesia was performed using 27G Quinke needle and 2.0 ml of 0.5% bupivacaine heavy with fentanyl 25 mcg was given.
After confirmation of subarachnoid block up to T6 level, 2 mg of midazolam was given to sedate the patient. Epidural block was maintained using continuous infusion of 0.25% bupivacaine from the epidural catheter. Surgery lasted for about 4 h and was uneventful and post-operatively transplant kidney was normal functioning.
Discussion
Wegener's granulomatosis is an autoimmune disease, which typically affects the kidneys as well as the upper and lower respiratory tracts. Involvement of the upper airways occurs with 95% prevalence in WG patients. Upper respiratory tract involvement causes frequently presenting symptoms such as ulcers and bloody nasal discharge. In addition to an upper respiratory tract contribution to the disease, lower respiratory tract symptoms may be present and may include cough, dyspnea, and hemoptysis in 85-90% of patients. 4 The diagnosis is suggested by the presence of circulating ANCAs that include perinuclear staining ANCA directed against myeloperoxidase (MPO-ANCA) and cytoplasmic staining ANCA against proteinase-3 (PR-3). Diagnosis is confirmed by biopsy demonstrating necrotizing granulomatous vasculitis. Our patient was in the 4th decade of his life when he presented with features of upper and lower respiratory tract involvement due to WG. His anti-MPO (ANCA) titers came out to be positive and were on cyclophosphamide and oral glucocorticoid medical therapy along with multiple antihypertensives.
Because of multisystem involvement of the disease, a proper preoperative assessment is required; evaluation of upper airways to recognize any ulcerative lesion along with Xray chest and pulmonary function test may be needed. Chest X-ray may reveal nodules, cavitations, consolidation, effusions, pleural thickening, or hilar lymphadenopathy. PFTs may show reduced lung volumes complicated by obstructive airway disease patterns. 4 Subglottic or tracheal stenosis occurs in 9-16% of these patients at some point. 5 Review of literature shows an acute upper airway obstruction and also reported a case of subglottic stenosis in pregnant patient of WG. 6 A regional anesthetic approach may be preferable to avoid airway instrumentation and its inherent complications in this population. 7 Because of several below given reasons, possibility of bleeding may be of concern during performance of central neuro-axial anaesthesia techniques, specially epidural block. So always take care of this by patient selection, normal coagulation, risk/benefit ratio and procedure to be done by experienced person. This tendency to bleed in these patients may arise due to (1) cytotoxic therapy (cyclophosphamide or methotrexate) leading into thrombocytopenia, (2) circulating immune complexes leading to a low grade disseminated intravascular coagulation, or (3) complications from general vasculitis and granulomatous inflammation with cutaneous, meningeal, or spinal hemorrhages. 8 As our patient was for renal transplantation with below umbilicus incision, normal coagulation and platelet functions, this surgery was planned under CSEA with additional benefit of not handling airway, avoiding cardiorespiratory involvement and better postoperative pain relief. 9 
4.

Conclusion
Although WG is rare and can have multiple organ involvement, there are special considerations for anesthetic management of these patients for renal transplantation. CSEA is a better alternative that minimizes airway handling and cardiopulmonary complication and provides better relaxation and postoperative analgesia in these high risk patients.
